OpenURL Connection Search

Select item for more details and to access through your institution.

Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer.
Published in:
2018
By:
- Kentaro Sawada;
- Yoshiaki Nakamura;
- Takeharu Yamanaka;
- Yasutoshi Kuboki;
- Daisuke Yamaguchi;
- Satoshi Yuki;
- Takayuki Yoshino;
- Yoshito Komatsu;
- Naoya Sakamoto;
- Wataru Okamoto;
- Satoshi Fujii;
- Sawada, Kentaro;
- Nakamura, Yoshiaki;
- Yamanaka, Takeharu;
- Kuboki, Yasutoshi;
- Yamaguchi, Daisuke;
- Yuki, Satoshi;
- Yoshino, Takayuki;
- Komatsu, Yoshito;
- Sakamoto, Naoya
Publication type:
journal article
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
Published in:
2019
By:
- Kotani, Daisuke;
- Kuboki, Yasutoshi;
- Horasawa, Satoshi;
- Kaneko, Asumi;
- Nakamura, Yoshiaki;
- Kawazoe, Akihito;
- Bando, Hideaki;
- Taniguchi, Hiroya;
- Shitara, Kohei;
- Kojima, Takashi;
- Tsuji, Akihito;
- Yoshino, Takayuki
Publication type:
journal article
How do we apply adjuvant FOLFOX to Japanese patients with curatively resected colorectal cancer?
Published in:
Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 2, p. 129, doi. 10.1111/j.1743-7563.2011.01385.x
By:
- SUENAGA, Mitsukuni;
- MATSUSAKA, Satoshi;
- WATANABE, Toshiyasu;
- KUBOKI, Yasutoshi;
- SHINOZAKI, Eiji;
- CHIN, Keisho;
- MIZUNUMA, Nobuyuki;
- UENO, Masashi;
- YAMAGUCHI, Toshiharu;
- HATAKE, Kiyohiko
Publication type:
Article
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer.
Published in:
Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920942377
By:
- Ishii, Takahiro;
- Kawazoe, Akihito;
- Sasaki, Akinori;
- Mishima, Saori;
- Kentaro, Sawada;
- Nakamura, Yoshiaki;
- Kotani, Daisuke;
- Kuboki, Yasutoshi;
- Taniguchi, Hiroya;
- Kojima, Takashi;
- Doi, Toshihiko;
- Yoshino, Takayuki;
- Kuwata, Takeshi;
- Ishii, Genichiro;
- Shitara, Kohei
Publication type:
Article
Four cases of paradoxical cephalocervical pyogenic granuloma during treatment with paclitaxel and ramucirumab.
Published in:
Journal of Dermatology, 2019, v. 46, n. 5, p. e178, doi. 10.1111/1346-8138.14693
By:
- Watanabe, Rei;
- Nakano, Eiji;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Shitara, Kouhei;
- Takahashi, Akira;
- Tsutsumida, Arata;
- Nishizawa, Aya;
- Yamazaki, Naoya
Publication type:
Article
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
Published in:
2018
By:
- Matsumoto, Hiroshi;
- Kawazoe, Akihito;
- Shimada, Kaoru;
- Fukuoka, Shota;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Kojima, Takashi;
- Ohtsu, Atsushi;
- Yoshino, Takayuki;
- Doi, Toshihiko;
- Shitara, Kohei
Publication type:
journal article
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials.
Published in:
BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2939-0
By:
- Yoshiaki Nagatani;
- Kohei Shitara;
- Hideaki Bando;
- Yasutoshi Kuboki;
- Wataru Okamoto;
- Takashi Kojima;
- Takayuki Yoshino;
- Toshirou Nishida;
- Atushi Ohtsu;
- Toshihiko Doi
Publication type:
Article
Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis.
Published in:
Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221146137
By:
- Yoshino, Takayuki;
- Taieb, Julien;
- Kuboki, Yasutoshi;
- Pfeiffer, Per;
- Kumar, Amit;
- Hochster, Howard S.
Publication type:
Article
Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009143
By:
- Chida, Keigo;
- Kotani, Daisuke;
- Nakamura, Yoshiaki;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Shitara, Kohei;
- Kojima, Takashi;
- Taniguchi, Hiroya;
- Watanabe, Jun;
- Endo, Itaru;
- Yoshino, Takayuki
Publication type:
Article
Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009143
By:
- Chida, Keigo;
- Kotani, Daisuke;
- Nakamura, Yoshiaki;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Shitara, Kohei;
- Kojima, Takashi;
- Taniguchi, Hiroya;
- Watanabe, Jun;
- Endo, Itaru;
- Yoshino, Takayuki
Publication type:
Article
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Published in:
British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
By:
- Kuboki, Yasutoshi;
- Terazawa, Tetsuji;
- Masuishi, Toshiki;
- Nakamura, Masato;
- Watanabe, Jun;
- Ojima, Hitoshi;
- Makiyama, Akitaka;
- Kotaka, Masahito;
- Hara, Hiroki;
- Kagawa, Yoshinori;
- Sugimoto, Naotoshi;
- Kawakami, Hisato;
- Takashima, Atsuo;
- Kajiwara, Takeshi;
- Oki, Eiji;
- Sunakawa, Yu;
- Ishihara, Soichiro;
- Taniguchi, Hiroya;
- Nakajima, Takako Eguchi;
- Morita, Satoshi
Publication type:
Article
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1413, doi. 10.1007/s10147-022-02200-1
By:
- Aoki, Yu;
- Kawazoe, Akihito;
- Kubota, Yohei;
- Chida, Keigo;
- Mishima, Saori;
- Kotani, Daisuke;
- Nakamura, Yoshiaki;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Kojima, Takashi;
- Doi, Toshihiko;
- Yoshino, Takayuki;
- Kuwata, Takeshi;
- Shitara, Kohei
Publication type:
Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
Published in:
International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
By:
- Kato, Takeshi;
- Kagawa, Yoshinori;
- Kuboki, Yasutoshi;
- Gamoh, Makio;
- Komatsu, Yoshito;
- Yasui, Hirofumi;
- Satake, Hironaga;
- Oki, Eiji;
- Tanioka, Hiroaki;
- Kotaka, Masahito;
- Makiyama, Akitaka;
- Denda, Tadamichi;
- Goto, Masahiro;
- Yoshino, Takayuki;
- Yamazaki, Kentaro;
- Soeda, Junpei;
- Shibuya, Kazunori;
- Iwata, Masaru;
- Oba, Koji;
- Yamaguchi, Kensei
Publication type:
Article
Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab.
Published in:
Medical Oncology, 2010, v. 27, n. 3, p. 807, doi. 10.1007/s12032-009-9289-6
By:
- Suenaga, Mitsukuni;
- Mizunuma, Nobuyuki;
- Kobayashi, Kokoro;
- Shinozaki, Eiji;
- Matsusaka, Satoshi;
- Chin, Keisho;
- Kuboki, Yasutoshi;
- Ichimura, Takashi;
- Ozaka, Masato;
- Ogura, Mariko;
- Fujiwara, Yoshimasa;
- Matsueda, Kiyoshi;
- Konishi, Fumio;
- Hatake, Kiyohiko
Publication type:
Article
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part.
Published in:
Cancer (0008543X), 2023, v. 129, n. 15, p. 2348, doi. 10.1002/cncr.34788
By:
- Doi, Toshihiko;
- Matsubara, Nobuaki;
- Naito, Yoichi;
- Kuboki, Yasutoshi;
- Harano, Kenichi;
- Ono, Makiko;
- Urasaki, Tetsuya;
- Ohmoto, Akihiro;
- Kawanai, Tsubasa;
- Hisai, Takashi;
- Ikezawa, Hiroki;
- Shiba, Sari;
- Ito, Ken;
- Semba, Taro;
- Asano, Osamu;
- Takahashi, Shunji
Publication type:
Article
Quantitative Analysis of the Concentration of Trifluridine in Tumor Hypoxic Regions Using a Novel Platform Combining Functional Endoscopy and Mass Spectrometry.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 62, doi. 10.1002/cpt.3066
By:
- Koganemaru, Shigehiro;
- Fuchigami, Hirobumi;
- Yamashita, Hiroki;
- Morizono, Chihiro;
- Sunakawa, Hironori;
- Kawazoe, Akihito;
- Nakamura, Yoshiaki;
- Kuboki, Yasutoshi;
- Shitara, Kohei;
- Yano, Tomonori;
- Doi, Toshihiko;
- Yasunaga, Masahiro
Publication type:
Article
Phase 1 study of napabucasin, a cancer stemness inhibitor, in patients with advanced solid tumors.
Published in:
2020
By:
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Fukuoka, Shota;
- Kojima, Takashi;
- Naito, Yoichi;
- Iino, Shuichi;
- Yodo, Yasuhide;
- Doi, Toshihiko;
- Shitara, Kohei;
- Yoshino, Takayuki
Publication type:
journal article
Quantitative analysis of drug distribution in heterogeneous tissues using dual‐stacking capillary electrophoresis–mass spectrometry.
Published in:
British Journal of Pharmacology, 2023, v. 180, n. 6, p. 762, doi. 10.1111/bph.15988
By:
- Koganemaru, Shigehiro;
- Kawai, Takayuki;
- Fuchigami, Hirobumi;
- Maeda, Naoyuki;
- Koyama, Kumiko;
- Kuboki, Yasutoshi;
- Mukohara, Toru;
- Doi, Toshihiko;
- Yasunaga, Masahiro
Publication type:
Article
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
Published in:
BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1276-z
By:
- Akihito Kawazoe;
- Kohei Shitara;
- Shota Fukuoka;
- Yasutoshi Kuboki;
- Hideaki Bando;
- Wataru Okamoto;
- Takashi Kojima;
- Nozomu Fuse;
- Takeharu Yamanaka;
- Toshihiko Doi;
- Atsushi Ohtsu;
- Takayuki Yoshino
Publication type:
Article
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.
Published in:
2015
By:
- Kawazoe, Akihito;
- Shitara, Kohei;
- Fukuoka, Shota;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Okamoto, Wataru;
- Kojima, Takashi;
- Fuse, Nozomu;
- Yamanaka, Takeharu;
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Yoshino, Takayuki
Publication type:
journal article
A phase 1/1b, open-label, dose-escalation study of PD-1 inhibitor, cetrelimab alone and in combination with FGFR inhibitor, erdafitinib in Japanese patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2024, v. 42, n. 4, p. 376, doi. 10.1007/s10637-024-01433-3
By:
- Yamamoto, Noboru;
- Kuboki, Yasutoshi;
- Harano, Kenichi;
- Koyama, Takafumi;
- Kondo, Shunsuke;
- Hagiwara, Akiko;
- Suzuki, Noriko;
- Fujikawa, Ei;
- Toyoizumi, Kiichiro;
- Mukai, Mayumi;
- Doi, Toshihiko
Publication type:
Article
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
Published in:
Investigational New Drugs, 2021, v. 39, n. 6, p. 1568, doi. 10.1007/s10637-021-01120-7
By:
- Naito, Yoichi;
- Kuboki, Yasutoshi;
- Ikeda, Masafumi;
- Harano, Kenichi;
- Matsubara, Nobuaki;
- Toyoizumi, Shigeyuki;
- Mori, Yuko;
- Hori, Natsuki;
- Nagasawa, Takashi;
- Kogawa, Takahiro
Publication type:
Article
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
Published in:
Investigational New Drugs, 2015, v. 33, n. 3, p. 632, doi. 10.1007/s10637-015-0227-5
By:
- Nishio, Makoto;
- Horiike, Atsushi;
- Nokihara, Hiroshi;
- Horinouchi, Hidehito;
- Nakamichi, Shinji;
- Wakui, Hiroshi;
- Ohyanagi, Fumiyoshi;
- Kudo, Keita;
- Yanagitani, Noriko;
- Takahashi, Shunji;
- Kuboki, Yasutoshi;
- Yamamoto, Noboru;
- Yamada, Yasuhide;
- Abe, Masaichi;
- Tahata, Takashi;
- Tamura, Tomohide
Publication type:
Article
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.
Published in:
Investigational New Drugs, 2015, v. 33, n. 3, p. 664, doi. 10.1007/s10637-015-0231-9
By:
- Kawazoe, Akihito;
- Shitara, Kohei;
- Fukuoka, Shota;
- Noguchi, Masaaki;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Okamoto, Wataru;
- Kojima, Takashi;
- Fuse, Nozomu;
- Yoshino, Takayuki;
- Ohtsu, Atsushi;
- Doi, Toshihiko
Publication type:
Article
Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.
Published in:
Japanese Journal of Clinical Oncology, 2018, v. 48, n. 6, p. 559, doi. 10.1093/jjco/hyy052
By:
- Naito, Yoichi;
- Takahashi, Hideaki;
- Shitara, Kohei;
- Okamoto, Wataru;
- Bando, Hideaki;
- Kuwata, Takeshi;
- Kuboki, Yasutoshi;
- Matsumoto, Shingo;
- Miki, Izumi;
- Yamanaka, Takeharu;
- Watanabe, Atsushi;
- Kojima, Motohiro
Publication type:
Article
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
Published in:
Cancer Science, 2024, v. 115, n. 5, p. 1622, doi. 10.1111/cas.16109
By:
- Hashimoto, Tadayoshi;
- Nakamura, Yoshiaki;
- Mishima, Saori;
- Nakayama, Izuma;
- Kotani, Daisuke;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Kojima, Takashi;
- Iida, Naoko;
- Shibuki, Taro;
- Imai, Mitsuho;
- Fujisawa, Takao;
- Nagamine, Michiko;
- Sakamoto, Naoya;
- Kuwata, Takeshi;
- Yoshino, Takayuki;
- Shitara, Kohei
Publication type:
Article
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors.
Published in:
Cancer Science, 2023, v. 114, n. 2, p. 574, doi. 10.1111/cas.15486
By:
- Doi, Toshihiko;
- Shitara, Kohei;
- Kojima, Takashi;
- Kuboki, Yasutoshi;
- Matsubara, Nobuaki;
- Bando, Hideaki;
- Yoh, Kiyotaka;
- Naito, Yoichi;
- Hirai, Hiroshi;
- Kurokawa, Yukinori;
- Kato, Terufumi;
- Morizane, Chigusa
Publication type:
Article
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
Published in:
Cancer Science, 2022, v. 113, n. 8, p. 2788, doi. 10.1111/cas.15443
By:
- Yonemori, Kan;
- Kuboki, Yasutoshi;
- Hasegawa, Kosei;
- Iwata, Takashi;
- Kato, Hidenori;
- Takehara, Kazuhiro;
- Hirashima, Yasuyuki;
- Kato, Hisamori;
- Passey, Chaitali;
- Buchbjerg, Jeppe Klint;
- Harris, Jeffrey R.;
- Andreassen, Camilla Mondrup;
- Nicacio, Leonardo;
- Soumaoro, Ibrahima;
- Fujiwara, Keiichi
Publication type:
Article
A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors.
Published in:
Cancer Science, 2022, v. 113, n. 3, p. 1010, doi. 10.1111/cas.15231
By:
- Doi, Toshihiko;
- Kuboki, Yasutoshi;
- Naito, Yoichi;
- Ishida, Masahiro;
- Tanaka, Tetsuya;
- Takeuchi, Yoshito
Publication type:
Article
Guidelines for clinical evaluation of anti‐cancer drugs.
Published in:
Cancer Science, 2021, v. 112, n. 7, p. 2563, doi. 10.1111/cas.14967
By:
- Minami, Hironobu;
- Kiyota, Naomi;
- Kimbara, Shiro;
- Ando, Yuichi;
- Shimokata, Tomoya;
- Ohtsu, Atsushi;
- Fuse, Nozomu;
- Kuboki, Yasutoshi;
- Shimizu, Toshio;
- Yamamoto, Noboru;
- Nishio, Kazuto;
- Kawakami, Yutaka;
- Nihira, Shin‐ichi;
- Sase, Kazuhiro;
- Nonaka, Takahiro;
- Takahashi, Hideaki;
- Komori, Yukiko;
- Kiyohara, Koshin
Publication type:
Article
PD‐1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Published in:
Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.6980
By:
- Kuboki, Yasutoshi;
- Koyama, Takafumi;
- Matsubara, Nobuaki;
- Naito, Yoichi;
- Kondo, Shunsuke;
- Harano, Kenichi;
- Yonemori, Kan;
- Yoh, Kiyotaka;
- Gu, Yuan;
- Mita, Tetsuya;
- Chen, Xuejun;
- Ueda, Eiji;
- Yamamoto, Noboru;
- Doi, Toshihiko;
- Shimizu, Toshio
Publication type:
Article
Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma.
Published in:
Cancer Medicine, 2023, v. 12, n. 15, p. 16066, doi. 10.1002/cam4.6260
By:
- Lee, Dae Ho;
- Kim, Hye Ryun;
- Keam, Bhumsuk;
- Kato, Ken;
- Kuboki, Yasutoshi;
- Gao, Haiyan;
- Yovine, Alejandro;
- Robbins, Scott H.;
- Ahn, Myung‐Ju
Publication type:
Article
FIGHT‐102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies.
Published in:
Cancer Medicine, 2023, v. 12, n. 9, p. 10597, doi. 10.1002/cam4.5798
By:
- Fujiwara, Yutaka;
- Kuboki, Yasutoshi;
- Furukawa, Masayuki;
- Mizuno, Nobumasa;
- Hara, Hiroki;
- Ioka, Tatsuya;
- Ueno, Makoto;
- Takahashi, Yasuo;
- Takahashi, Shunji;
- Takeuchi, Shinji;
- Lihou, Christine;
- Ji, Tao;
- Tian, Chenwei;
- Shimizu, Toshio
Publication type:
Article
Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study.
Published in:
Cancer Medicine, 2021, v. 10, n. 19, p. 6579, doi. 10.1002/cam4.4110
By:
- Doi, Toshihiko;
- Yamamoto, Noboru;
- Naito, Yoichi;
- Kuboki, Yasutoshi;
- Koyama, Takafumi;
- Piao, Yongzhe;
- Tsujimoto, Naoto;
- Asou, Hiroya;
- Inoue, Koichi;
- Kondo, Shunsuke
Publication type:
Article
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience.
Published in:
Gastric Cancer, 2023, v. 26, n. 6, p. 1030, doi. 10.1007/s10120-023-01427-9
By:
- Okunaka, Mashiro;
- Kawazoe, Akihito;
- Nakamura, Hitomi;
- Kotani, Daisuke;
- Mishima, Saori;
- Kuboki, Yasutoshi;
- Nakamura, Yoshiaki;
- Shitara, Kohei
Publication type:
Article
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
Published in:
Gastric Cancer, 2020, v. 23, n. 5, p. 893, doi. 10.1007/s10120-020-01058-4
By:
- Sasaki, Akinori;
- Nakamura, Yoshiaki;
- Togashi, Yosuke;
- Kuno, Hirofumi;
- Hojo, Hidehiro;
- Kageyama, Shunichiro;
- Nakamura, Naoki;
- Takashima, Kenji;
- Kadota, Tomohiro;
- Yoda, Yusuke;
- Mishima, Saori;
- Sawada, Kentaro;
- Kotani, Daisuke;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Taniguchi, Hiroya;
- Kojima, Takashi;
- Doi, Toshihiko;
- Yoshino, Takayuki;
- Yano, Tomonori
Publication type:
Article
Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer.
Published in:
Gastric Cancer, 2019, v. 22, n. 4, p. 793, doi. 10.1007/s10120-018-00922-8
By:
- Sasaki, Akinori;
- Nakamura, Yoshiaki;
- Mishima, Saori;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Kojima, Takashi;
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Yoshino, Takayuki;
- Kuwata, Takeshi;
- Akimoto, Tetsuo;
- Shitara, Kohei
Publication type:
Article
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
Published in:
Gastric Cancer, 2019, v. 22, n. 1, p. 69, doi. 10.1007/s10120-018-0843-9
By:
- Kawazoe, Akihito;
- Shitara, Kohei;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Kojima, Takashi;
- Yoshino, Takayuki;
- Ohtsu, Atsushi;
- Ochiai, Atsushi;
- Togashi, Yosuke;
- Nishikawa, Hiroyoshi;
- Doi, Toshihiko;
- Kuwata, Takeshi
Publication type:
Article
In situ analysis of FGFR2 mRNA and comparison with <italic>FGFR2</italic> gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients.
Published in:
Gastric Cancer, 2018, v. 21, n. 3, p. 401, doi. 10.1007/s10120-017-0758-x
By:
- Kuboki, Yasutoshi;
- Schatz, Christoph A.;
- Koechert, Karl;
- Schubert, Sabine;
- Feng, Janine;
- Wittemer-Rump, Sabine;
- Ziegelbauer, Karl;
- Krahn, Thomas;
- Nagatsuma, Akiko Kawano;
- Ochiai, Atsushi
Publication type:
Article
Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Published in:
Gastric Cancer, 2017, v. 20, n. 3, p. 407, doi. 10.1007/s10120-016-0631-3
By:
- Kawazoe, Akihito;
- Kuwata, Takeshi;
- Kuboki, Yasutoshi;
- Shitara, Kohei;
- Nagatsuma, Akiko;
- Aizawa, Masaaki;
- Yoshino, Takayuki;
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Ochiai, Atsushi
Publication type:
Article
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Published in:
Gastric Cancer, 2016, v. 19, n. 1, p. 183, doi. 10.1007/s10120-015-0471-6
By:
- Fuse, Nozomu;
- Kuboki, Yasutoshi;
- Kuwata, Takeshi;
- Nishina, Tomohiro;
- Kadowaki, Shigenori;
- Shinozaki, Eiji;
- Machida, Nozomu;
- Yuki, Satoshi;
- Ooki, Akira;
- Kajiura, Shinya;
- Kimura, Tetsuo;
- Yamanaka, Takeharu;
- Shitara, Kohei;
- Nagatsuma, Akiko;
- Yoshino, Takayuki;
- Ochiai, Atsushi;
- Ohtsu, Atsushi
Publication type:
Article
TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer.
Published in:
Cancer Medicine, 2015, v. 4, n. 11, p. 1667, doi. 10.1002/cam4.515
By:
- Fujii, Satoshi;
- Fujihara, Ayano;
- Natori, Kei;
- Abe, Anna;
- Kuboki, Yasutoshi;
- Higuchi, Youichi;
- Aizawa, Masaki;
- Kuwata, Takeshi;
- Kinoshita, Takahiro;
- Yasui, Wataru;
- Ochiai, Atsushi
Publication type:
Article
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
Published in:
Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
By:
- Sunakawa, Yu;
- Kuboki, Yasutoshi;
- Watanabe, Jun;
- Terazawa, Tetsuji;
- Kawakami, Hisato;
- Yokota, Mitsuru;
- Nakamura, Masato;
- Kotaka, Masahito;
- Sugimoto, Naotoshi;
- Ojima, Hitoshi;
- Oki, Eiji;
- Kajiwara, Takeshi;
- Yamamoto, Yoshiyuki;
- Tsuji, Yasushi;
- Denda, Tadamichi;
- Tamura, Takao;
- Ishihara, Soichiro;
- Taniguchi, Hiroya;
- Nakajima, Takako Eguchi;
- Morita, Satoshi
Publication type:
Article
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.
Published in:
2022
By:
- Shimizu, Toshio;
- Kuboki, Yasutoshi;
- Lin, Chia-Chi;
- Yonemori, Kan;
- Yanai, Tomoko;
- Faller, Douglas V.;
- Dobler, lwona;
- Gupta, Neeraj;
- Sedarati, Farhad;
- Kim, Kyu-pyo
Publication type:
Correction Notice
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.
Published in:
2022
By:
- Shimizu, Toshio;
- Kuboki, Yasutoshi;
- Lin, Chia-Chi;
- Yonemori, Kan;
- Yanai, Tomoko;
- Faller, Douglas V.;
- Dobler, lwona;
- Gupta, Neeraj;
- Sedarati, Farhad;
- Kim, Kyu-pyo
Publication type:
journal article
Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.
Published in:
Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1757, doi. 10.1093/jjco/hyab159
By:
- Mizuno, Takaaki;
- Yoshida, Tatsuya;
- Sunami, Kuniko;
- Koyama, Takafumi;
- Okita, Natsuko;
- Kubo, Takashi;
- Sudo, Kazuki;
- Shimoi, Tatsunori;
- Ueno, Hideki;
- Saito, Eiko;
- Katanoda, Kota;
- Shibata, Taro;
- Yonemori, Kan;
- Okusaka, Takuji;
- Boku, Narikazu;
- Ohe, Yuichiro;
- Hiroshima, Yukihiko;
- Ueno, Makoto;
- Kuboki, Yasutoshi;
- Doi, Toshihiko
Publication type:
Article
Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer.
Published in:
2017
By:
- Fukuoka, Shota;
- Shitara, Kohei;
- Noguchi, Masaaki;
- Kawazoe, Akihito;
- Kuboki, Yasutoshi;
- Bando, Hedeaki;
- Okamoto, Wataru;
- Kojima, Takashi;
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Yoshino, Takayuki
Publication type:
journal article
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution.
Published in:
2016
By:
- Kotani, Daisuke;
- Shitara, Kohei;
- Kawazoe, Akihito;
- Fukuoka, Shota;
- Kuboki, Yasutoshi;
- Bando, Hideaki;
- Okamoto, Wataru;
- Kojima, Takashi;
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Yoshino, Takayuki
Publication type:
journal article

Found: 48